An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan Protects Against Neurological Deficits and Prolongs Survival in Spontaneously Hypertensive Rats Stroke-Prone (SHR-SP) Infused with Ang II

Publisher： Bentham Science Publishers

E-ISSN： 1875-5844|4|2|151-154

ISSN： 1567-2700

Source： Vascular Disease Prevention, Vol.4, Iss.2, 2007-05, pp. : 151-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation

By Isobe Aki   Takeda Takashi   Sakata Masahiro   Miyake Asako   Yamamoto Toshiya   Minekawa Ryoko   Nishimoto Fumihito   Oskamoto Yoko   Walker Cheryl Lyn   Kimura Tadashi  

Human Reproduction, Vol. 23, Iss. 2, 2008-02 ,pp. : 440-446

Oxford University Press

Access to resources Recommend Favorite

Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats

By Ueki Masaru   Koda Masahiko   Yamamoto Satoru   Matsunaga Yoshiko   Murawaki Yoshikazu  

Journal of Gastroenterology, Vol. 41, Iss. 10, 2006-10 ,pp. : 996-1004

Springer Publishing Company

Access to resources Recommend Favorite

AngII residues in the regulation of receptor activity

By Olivares-Reyes J.A.   Hernandez-Aranda J.  

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 5, 2002-07 ,pp. : 188-188

Elsevier

Access to resources Recommend Favorite

Anti-Albuminuric Effects of the Angiotensin AT1 Receptor Blocker Telmisartan in Hypertensive Patients

By Rodríguez-Pérez José C.   García-Bello Miguel A.   Anabitarte-Prieto Aránzazu   Companioni Osmel   Nóvoa-Mogollón Francisco J.   Suárez-Ortega Saturnino   Plaza-Toledano Celia   Rodríguez-Esparragón Francisco  

Clinical and Experimental Hypertension, Vol. 33, Iss. 8, 2011-12 ,pp. : 506-510

Informa Healthcare

Access to resources Recommend Favorite

Ambulatory Blood Pressure Monitoring to Assess the Comparative Efficacy and Duration of Action of a Novel New Angiotensin II Receptor Blocker - Telmisartan

By Neutel Joel M.  

Blood Pressure, Vol. 10, Iss. 1, 2001-02 ,pp. : 27-32

Informa Healthcare

Access to resources Recommend Favorite